Hillaire S, Bonte E, Denninger M-H, Casadevall N, Cadranel J-F, Lebrec D, Valla D, Degott C
Service d'Hépatologie and INSERM U 481, Hôpital Beaujon, 92118 Clichy, France.
Gut. 2002 Aug;51(2):275-80. doi: 10.1136/gut.51.2.275.
Non-cirrhotic portal hypertension of unknown cause is a poorly understood condition attributed to obstructive portal venopathy.
To reassess the manifestations, course, and causes, with special attention to thrombosis.
Analysis of a cohort of 28 patients.
Gastrointestinal bleeding occurred in 11 patients. Liver failure developed at the time of concurrent disease in eight patients, including all four patients who died. Portal vein thrombosis developed in 13 patients. A prothrombotic disorder was found in 12 of 23 fully investigated patients. Hepatoportal sclerosis was observed in 11 patients (with associated perisinusoidal fibrosis and/or nodular regenerative hyperplasia in six); periportal fibrosis, perisinusoidal fibrosis, nodular regenerative hyperplasia, or a combination thereof were observed in other patients. A morphometric evaluation showed an increased number of portal vessels in patients with hepatoportal sclerosis. There was no relation between pathological results and haemodynamic findings or prothrombotic disorders.
Outcome was related to associated conditions. Overlap in pathological, haemodynamic, and causal features suggests a single entity, with prothrombotic disorders as major causal factors, and injury to sinusoids as well as to portal venules as the primary mechanism. Activated coagulation could mediate vascular injury in the absence of thrombosis. Anticoagulation should be considered.
病因不明的非肝硬化门静脉高压是一种了解甚少的疾病,归因于阻塞性门静脉病。
重新评估其表现、病程及病因,特别关注血栓形成情况。
对28例患者的队列进行分析。
11例患者发生胃肠道出血。8例患者在并发疾病时出现肝功能衰竭,包括所有4例死亡患者。13例患者发生门静脉血栓形成。在23例接受全面检查的患者中,12例发现存在血栓前状态。11例患者观察到肝门脉硬化(其中6例伴有窦周纤维化和/或结节性再生性增生);其他患者观察到门静脉周围纤维化、窦周纤维化、结节性再生性增生或其组合。形态学评估显示肝门脉硬化患者的门静脉数量增加。病理结果与血流动力学表现或血栓前状态之间无关联。
预后与相关疾病有关。病理、血流动力学和病因特征的重叠提示为单一疾病实体,血栓前状态为主要病因因素,窦状隙和门静脉小分支损伤为主要机制。在无血栓形成的情况下,活化凝血可能介导血管损伤。应考虑抗凝治疗。